Medical Technology Venture Partners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Centesecentese.comin𝕏May 2026
Centese develops Thoraguard, a digital surgical drainage system for cardiothoracic surgery that automates chest tube clog clearance and measures air leak rate and drainage volume, alerting care teams to disruptions.
Digital HealthHardwareHealthtechMedical DevicesOmaha, US
Evan Luxon(Executive Officer, Director)inRandy Preston(CEO)Alan Chesler(Director)Dan Burnett(Director)
BoardDaniel Burnett(Director)
Board seatRadu Cautis· per SEC Form D
Co-investorsInvest NebraskaNew York AngelsScientific Health Development
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.